相关实验视频

Updated: Jun 23, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

在药物发现中揭开幕:聚焦未经探索的脚手架

Yie Kie Chong¹, Yee Swen Ong¹, Keng Yoon Yeong¹

¹School of Science, Monash University Malaysia Campus Jalan Lagoon Selatan 47500 Bandar Sunway Selangor Malaysia Yeong.kengyoon@monash.edu.

RSC medicinal chemistry

|June 24, 2024

概括

循环硫胺 (sultams) 显示出超越抗菌用途的希望,研究探索抗癌,抗炎症,抗糖尿病和抗病毒活动. 本审查审查了苏丹的衍生品.

科学领域:

药用化学医学化学
有机化学有机化学
药理学药理学是指药理学的学科.

背景情况:

循环硫胺 (sultams) 在历史上被认为具有抗菌性质.
最近的研究突出了苏尔塔姆在各种治疗领域的潜力,包括抗癌,抗炎症,抗糖尿病和抗病毒应用.
尽管有很大的前景,但大多数苏丹研究仍处于发现阶段,商业药物可用性有限.

研究的目的:

巩固和审查苏丹衍生物不断扩大的生物活动.
为了研究具有从4到8个成员的环状结构的sultam化合物.
为了强调苏丹在药物发现和制药研究中日益重要的重要性.

主要方法:

关于苏丹衍生物的科学出版物的文献综述.
对各种治疗类别中报告的生物活性进行分析.
根据戒指大小 (4至8个成员) 来分类苏拉姆衍生品.

主要成果:

苏尔塔姆衍生品表现出超越抗菌作用的广泛的生物活性.
确定了在瘤学,炎症,代谢障碍和病毒学方面的潜在应用.
编制关于苏丹体结构及其相关生物活性的数据.

结论:

苏尔塔姆衍生物代表了一类具有显著治疗潜力的多功能化合物.
需要进一步的研究和开发,以将有前途的发现转化为临床应用.
苏尔塔姆仍然是现代药物发现的关键重点领域.

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...